# Conbercept vs Panretinal Photocoagulation for the Management of Proliferative Diabetic Retinopathy

> **NCT02911311** · NA · UNKNOWN · sponsor: **Sun Yat-sen University** · enrollment: 226 (estimated)

## Conditions studied

- Proliferative Diabetic Retinopathy

## Interventions

- **DRUG:** intravitreal injection of conbercept
- **DEVICE:** PRP

## Key facts

- **NCT ID:** NCT02911311
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-10-12
- **Primary completion:** 2022-12
- **Final completion:** 2022-12
- **Target enrollment:** 226 (ESTIMATED)
- **Last updated:** 2021-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02911311

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02911311, "Conbercept vs Panretinal Photocoagulation for the Management of Proliferative Diabetic Retinopathy". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02911311. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*